Compare RGEN & ESLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | ESLT |
|---|---|---|
| Founded | 1981 | 1966 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 43.0B |
| IPO Year | 1995 | 2002 |
| Metric | RGEN | ESLT |
|---|---|---|
| Price | $116.90 | $820.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $167.67 | ★ $667.00 |
| AVG Volume (30 Days) | ★ 817.5K | 110.9K |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | $14.29 |
| Revenue Next Year | $14.52 | $8.49 |
| P/E Ratio | $131.21 | ★ $71.88 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $109.50 | $369.60 |
| 52 Week High | $175.77 | $1,016.06 |
| Indicator | RGEN | ESLT |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 38.43 |
| Support Level | $111.29 | $810.00 |
| Resistance Level | $131.93 | $950.10 |
| Average True Range (ATR) | 6.15 | 23.65 |
| MACD | -0.27 | -12.29 |
| Stochastic Oscillator | 23.16 | 14.25 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security and commercial flight capabilities. Its systems and solutions may be installed on new platforms or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company operates in five segments: Aerospace; C4I and Cyber; ISTAR and EW; Land; and ESA. It derives maximum revenue from Land Segment. Geographically, it operates in Israel; North America; Europe; Asia-Pacific; Latin America; and Others.